A retrospective study to determine clinical response and remission rates with vedolizumab
Latest Information Update: 23 Jul 2021
At a glance
- Drugs Vedolizumab (Primary)
- Indications Crohn's disease; Ulcerative colitis
- Focus Therapeutic Use
- 23 Jul 2021 New trial record